10.02.2016

The medicine industry is more and more affected by the clawback tax, as the tax currently accounts for approximately 30% of the value added of a drugmaker, which will soon lead to the collapse of drug more

08.01.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported sales of RON143.8 million in January-June 2016, up 9% from the year-earlier period. more

07.11.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) has called a shareholders' meeting for August 11 to approve the contracting of a RON30 million (EUR6.7 million) loan from a UniCredit Bank. more

07.07.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) in June finished the delivery of a $3.4 million order for injectable medicines to the United States. more

05.17.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a profit of RON7.1 million in January-March 2016, up 18% from the year-earlier period. more

05.13.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a turnover of RON55.1 million in the first quarter of 2016, up 5% from RON52.6 million in the year-earlier period and 1% higher than the more

04.20.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) targets revenues of RON350 million and a gross profit of RON34.2 million in 2016, both 6% higher on the year, given negative factors such as the more

02.15.2016

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit of RON27.1 million in 2015, down from RON31.1 million a year before, but higher than forecasted, the company said in a more

09.16.2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Tuesday said on the Bucharest Stock Exchange it will suspend the payment of the dividends due for 2011 and not cashed by the stockholders, on more

08.10.2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported 11.6% lower sales revenue in the first half of 2015, to RON132.39 million (EUR30 million), in the context in which the local market was more

05.28.2015

State-run pharmaceutical producer Antibiotice Iasi (ATB.RO) intends to build two more manufacturing lines in a total investment of EUR40 million and secure the necessary funding by attracting a more

05.15.2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit of 6 million lei (EUR1.4 million) for the first quarter, up 15% on the year, the company said in a statement Friday. more

04.30.2015

Shareholders of Romanian pharmaceutical producer Antibiotice Iasi (ATB.RO) Thursday approved the payment of dividends worth 15.74 million lei (EUR3.5 million), or half of last year’s profit, the more

03.27.2015

Romanian pharmaceutical producer Antibiotice Iasi (ATB.RO) plans to pay dividends of 15.74 million lei (EUR3.5 million), about half of last year’s net profit, according to documents prepared for the more

03.12.2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) estimates its net profit will fall by 32% to RON21.26 million (nearly EUR4.8 million) in 2015, from RON31.29 million a year before. more

02.13.2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Friday said its sales revenue inched up 0.5% on the year in 2014, to 318.9 million lei (EUR71.8 million), while its profit stagnated at nearly more

01.09.2015

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will collaborate with three Indian pharmaceutical companies to research and develop new drugs, according to Indian publication The Economic more

12.24.2014

Romanian state-run drug maker Antibiotice Iasi says its exports, weighing 30% in revenue, felt the fallout of declining prices internationally, as well as of the crisis in Russia and Ukraine. The more

11.14.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Friday said its sales revenues were flat on the year at 217.2 million lei (EUR48.8 million) in January-September 2014. more

08.14.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported a net profit worth 18.3 million lei (EUR4.09 million) in January-June, up 6.3% from RON17.21 million in the corresponding period a year more

06.26.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will extend by one year its 60 million lei (some EUR13 million) credit line signed with EximBank in July 2013, according to a shareholders’ more

06.20.2014

Health Ministry-owned drug producer Antibiotice Iasi (ATB.RO) will invest EUR10 million in a new ointment and suppository production facility in 2014-2016, whose products it will sell in Romania and more

05.15.2014

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Thursday reported a 2% increase in sales revenue to 60.55 million lei (EUR13.6 million) in the first quarter of 2014, from RON59.44 million in more

05.08.2014

Romanian state-run drug-maker Antibiotice Iasi (ATB.RO wants to build new production facilities to develop its product portfolio and estimates it will invest EUR40 million over the next six years, more

05.01.2014

Antibiotice Iasi (ATB.RO) plans to boost revenue by stepping up exports and launching new products. The company ranks 11th among the biggest players on the Romanian pharmaceutical market. more